CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,093 enrolled
Drug / intervention
questionnaireother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06035926
NCT06035926N/ACompleted

Survey of Symptoms After a COVID Vaccination in Employees: a Retrospective Study.

Medical University of Graz·observational·Posted Sep 13, 2023·Updated Sep 13, 2023

In Brief

An observational study evaluating questionnaire for Symptoms Recoding SARS-CoV-2 After Vaccination. Completed, enrolled 1,093 participants across 1 site.

Detailed Summary

Background: SARS-CoV-2 (Severe acute respiratory syndrome coronavirus type 2) has had us firmly in its grip for more than two years. In January 2021, the quality and risk management unit of the LKH (Landeskrankenhaus) -Univ. Klinikum Graz commissioned to carry out vaccinations for employees and subsequently for high-risk patients. In the vaccination line, which was open for 85 days in 2021/22, the vaccines from Astra Zeneca, Biontech-Pfizer and Moderna were vaccinated. There were hardly any complications. The primary immunization, booster vaccination and booster vaccination were carried out. Despite the small number of incidents in the sense of an immediate reaction, there were numerous sick leave. Methods: For this reason, in the course of the booster vaccination, starting from October 2021 to January 2022, every vaccinated person was asked to fill out a questionnaire. Participation was voluntary and was supported by the works councils of the Medical University and the LKH-University clinic Graz approved. The survey served to retrospectively record how many employees developed symptoms in response to the respective vaccination. With this approach it will be possible to subject the responses to an in-depth statistical analysis in order to obtain a data-based contribution to the side effects of vaccines categorized with different vaccination schemes.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesAustria
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 13, 2023
Enrollment StartJan 1, 2021
Primary CompletionJul 31, 2023
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 2.8 years ago

Interventions

questionnaireother

questionnaire